cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rapt Therapeutics Inc
7 own
5 watching
Current Price
$27.45
$-0.51
(-1.82%)
logo-rapt
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
820.38M
52-Week High
52-Week High
32.45
52-Week Low
52-Week Low
9.855
Average Volume
Average Volume
0.7M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization820.38M
icon52-Week High32.45
icon52-Week Low9.855
iconAverage Volume0.7M
iconDividend Yield--
iconP/E Ratio--
What does the Rapt Therapeutics Inc do?
RAPT Therapeutics, Inc.is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Read More
How much money does Rapt Therapeutics Inc make?
News & Events about Rapt Therapeutics Inc.
Globe Newswire
24days ago
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in ...
Globe Newswire
1month ago
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc.(Nasdaq: RAPT) (RAPT or the Company), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant ...
Globe Newswire
2 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc.(Nasdaq: RAPT) (RAPT or the Company), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant ...
Globe Newswire
2 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in ...
Market News Video
2 months ago
In trading on Friday, shares of RAPT Therapeutics Inc (RAPT) crossed below their 200 day moving average of 20.72, changing hands as low as 20.04 per share. RAPT Therapeutics Inc shares are currently trading down about 3.1% on the day...
Frequently Asked Questions
Frequently Asked Questions
What is Rapt Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Rapt Therapeutics Inc shares?
plus_minus_icon
How can I buy Rapt Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Rapt Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rapt Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Rapt Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Rapt Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rapt Therapeutics Inc?
plus_minus_icon
What percentage is Rapt Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rapt Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$27.45
$-0.51
(-1.82%)
logo-rapt
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
ARCUTIS BIOTHERAPEUTICS INC
ARCUTIS BIOTHERAPEUTICS INC
$16.10
$-0.03 (-0.19 %)
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
$27.93
$-0.03 (-0.11 %)
Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd
$13.77
$-0.19 (-1.36 %)
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc
$23.68
$0.06 (0.25 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
ARCUTIS BIOTHERAPEUTICS INC
ARCUTIS BIOTHERAPEUTICS INC
$16.10
$-0.03 (-0.19 %)
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
$27.93
$-0.03 (-0.11 %)
Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd
$13.77
$-0.19 (-1.36 %)
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc
$23.68
$0.06 (0.25 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00